Preferential dysregulation of genes exhibiting elevated mCH levels in the case of MeCP2 disorders suggests that MeCP2 binding to mCH loci is integral to neuronal gene expression. Moreover, MeCP2 has a higher affinity for mCH compared to Bdnf which is linked to RTT’s pathophysiology. This evidence concerns the gene PMCH and Rett syndrome.